arrow
返回
L

Ltd

学者数589
论文数300
被引数0
关联论文 (299)
发表时间
An operational perturbation proteomics-based virtual cell model基于操作扰动蛋白质组学的虚拟细胞模型
errNature
IF48.5
err2026-09-09
err0
PREAI
errRui Sun; Liujia Qian; Yongge Li; Tong Liu; Honghan Cheng; Xuedong Zhang; Xueya Zhou; Yuecheng Zhan; Guangmei Zhang; Zhengchao Luo; Kunpeng Ma; Chunlong Wu; Dongchen Ji; Zhangzhi Xue; Hongxue Meng; Yuhang Xiang; Dingwei Lei; Qianhe Zhou; Wenbin Hu; Yuhan Deng; Lingling Tan; Qi Xiao; Zhiwei Liu; Lei Zeng; Liqin Qian; Xuan Zheng; Qiong Hu; Nianzi Luo; Weinan E; Peijie Zhou; Han Wen; Yi Zhu; Tiannan Guo
err分享
err收藏
Supramolecular janus eutectic engineered from panthenol and bisabolol overcomes transdermal delivery paradoxes由泛醇和没药醇构建的超分子Janus低共熔体克服了经皮递送悖论
err2026-09-08
err0
errOAAI
errHao WANG; Qingsheng TAO; Xiaofeng HE; Kung Chi HSU; Yu GAO; Delphine KEROB; Wei LIU; Zhenyuan WANG; Nan HUANG; Jiaheng ZHANG
err分享
err收藏
Extracellular vesicle proteins monitor and interfere with CLDN18.2-targeted CAR-T cell and antibody therapies against gastrointestinal cancers外泌体蛋白监测并干扰CLDN18.2靶向CAR-T细胞和抗体疗法对胃肠道肿瘤的治疗
err2026-09-03
err0
errOAAI
errChangsong Qi; Mingyang Ma; Kaijie Liang; Chang Liu; Jiarui Li; Yakun Wang; Dan Liu; Miao Zhang; Xiaoyi Chong; Fangli Jiang; Shengde Liu; Zizhen Zhang; Congcong Ji; Yuezong Bai; Meng Fan; Chuanhui Han; Xiaotian Zhang; Jifang Gong; Jian Li; Lin Shen; Cheng Zhang
err分享
err收藏
Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trialDisitamab vedotin用于HER2阳性肝转移性乳腺癌:RC48-C006 II/III期试验的III期结果
err2026-08-27
err0
errOAAI
errJiayu Wang; Quchang Ouyang; Weimin Xie; Zhaofeng Niu; Qingyuan Zhang; Xi Yan; Yue’e Teng; Jianying Chang; Ying Cheng; Airong Wang; Jingfen Wang; Herui Yao; Zhuangqing Yang; Tao Sun; Zhongsheng Tong; Xinhong Wu; Yongsheng Wang; Enxiang Zhou; Xiangshun Kong; Xujuan Wang; De Zeng; Shanshan Gu; Yanyan Hou; Dandan Gao; Zerui Qu; Chenran Han; Jianmin Fang; Binghe Xu
err分享
err收藏